Literature DB >> 31656770

Is survival after sublobar resection vs. lobectomy made equivalent by extent of lymphadenectomy?

Kimberly J Song1, Raja M Flores1.   

Abstract

Year:  2019        PMID： 31656770      PMCID： PMC6789343          DOI： 10.21037/atm.2019.07.33

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  9 in total

1.  Mediastinal lymph node dissection: the debate is not resolved.

Authors:  Jeffrey Shayani; Raja M Flores; Ardeshir Hakami
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.

Authors:  Bradley G Ackerson; Betty C Tong; Julian C Hong; Lin Gu; Junzo Chino; Jacob W Trotter; Thomas A D'Amico; Jordan A Torok; Kyle Lafata; Catherine Chang; Chris R Kelsey
Journal:  Lung Cancer       Date:  2018-09-25       Impact factor: 5.705

3.  Adequacy of Intraoperative Nodal Staging during Surgical Resection of NSCLC: Influencing Factors and Its Relationship to Survival.

Authors:  Tim Edwards; Haval Balata; Mohamed Elshafi; Philip Foden; Paul Bishop; Eustace Fontaine; Mark Jones; Piotr Krysiak; Kandadai Rammohan; Rajesh Shah; Philip Crosbie; Richard Booton; Matthew Evison
Journal:  J Thorac Oncol       Date:  2017-08-04       Impact factor: 15.609

4.  Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Authors:  Jinlin Cao; Ping Yuan; Yiqing Wang; Jinming Xu; Xiaoshuai Yuan; Zhitian Wang; Wang Lv; Jian Hu
Journal:  Ann Thorac Surg       Date:  2018-02-17       Impact factor: 4.330

5.  Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.

Authors:  Brendon M Stiles; Jialin Mao; Sebron Harrison; Benjamin Lee; Jeffrey L Port; Art Sedrakyan; Nasser K Altorki
Journal:  J Thorac Cardiovasc Surg       Date:  2019-02-28       Impact factor: 5.209

6.  Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Yusuke Tanaka; Daisuke Saito; Shuhei Yoshida; Seiichi Kakegawa; Tomoyasu Kumano; Yosuke Shimizu; Hiroyasu Tamamura; Tsuyoshi Takanaka; Hirofumi Takemura
Journal:  Ann Thorac Surg       Date:  2018-11-17       Impact factor: 4.330

7.  Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer?

Authors:  Elizabeth A David; David T Cooke; Yingjia Chen; Kieranjeet Nijar; Robert J Canter; Rosemary D Cress
Journal:  Ann Thorac Surg       Date:  2016-07-26       Impact factor: 4.330

8.  Selective versus systematic lymph node dissection (other than sampling) for clinical N2-negative non-small cell lung cancer: a meta-analysis of observational studies.

Authors:  Han Han; Yue Zhao; Haiquan Chen
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer.

Authors:  Wenfei Xue; Guochen Duan; Xiaopeng Zhang; Hua Zhang; Qintao Zhao; Zhifei Xin
Journal:  Onco Targets Ther       Date:  2018-06-07       Impact factor: 4.147
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.